Fig. 5From: Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysisOverall survival analysis of prognostic hub genes in liver hepatocellular carcinoma (LIHC) was performed by using the UALCAN platform. Survival analysis curve for CDK1 (a), HMMR (b), PTTG1 (c), and TTK (d) in patients with LIHC from The Cancer Genome Atlas (TCGA). Log-rank test was performed on the relevant resultsBack to article page